EMEA-000275-PIP01-08

Key facts

Active substance
Rolofylline
Therapeutic area
Cardiovascular diseases
Decision number
P/87/2009
PIP number
EMEA-000275-PIP01-08
Pharmaceutical form(s)
Emulsion for injection
Condition(s) / indication(s)
Heart Failure
Route(s) of administration
Intravenous use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.
E-mail: axel_breitstadt@merck.com
Country: Belgium
Phone: +32 27766045
Fax: +32 27766288
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating